News
Regenative Labs & Dr. Michael Lavor: Charcot Foot Study
Apr 24, 2023
Study approved by institutional review board of the Institute of Regenerative and Cellular Medicine. April 24, 2023—Regenative Labs (Regenative), a… Read More >
Regenative Labs Presents Wharton’s Jelly Studies at Wound Care Symposium
Apr 10, 2023
April 10, 2023, Pensacola, FL— Regenative Labs (Regenative), a leading provider of regenerative medicine solutions, announced that it will present… Read More >
Regenative Labs Updates Wharton’s Jelly Knee Study
Feb 20, 2023
New data demonstrates statistically significant reported WOMAC improvement. February 20, 2023, Pensacola, FL – Regenative Labs (Regenative), a leading HCT/P… Read More >
Regenative Labs & Dr. Albert Lai: Wharton’s Jelly in Si Joint Care
Jan 19, 2023
January 19, 2023. Pensacola, FL— Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective analysis of patients who have… Read More >
Regenative Labs: Wharton’s Jelly in Post-Surgical Breast Care
Jan 09, 2023
January 9, 2023, Pensacola, FL— Regenative Labs (Regenative), a leading HCT/P manufacturer has published a case study in the Journal… Read More >
Advances through Value-Based Outcomes
Nov 30, 2022
This month marks five years since the FDA HCT/P regulations were first introduced. In that time we have (1) produced… Read More >
Regenative Labs announces groundbreaking Wharton’s Jelly research demonstrating HCT/P compliance after processing
Aug 15, 2022
This includes the analogous nature of articular cartilage, muscle fascia, and intervertebral disc confirmed by way of comparative Scanning Electron… Read More >
Regenative Labs Releases New Study To Revolutionize Treatment For Patients With Diabetic Foot Ulcers
Aug 08, 2022
Future applications for the early, preventative use of amniotic membrane allografts in addition to the current standard of care for… Read More >